Chronic Kidney Disease
Chronic Kidney Disease
Part of NephTimes
Advertisement
Charlotte RobinsonChronic Kidney Disease | April 2, 2025
A partnership will provide education to primary care clinicians to strengthen identification and treatment of kidney disease.
Charlotte RobinsonChronic Kidney Disease | March 31, 2025
A study examined the association of ankle-brachial index and CKD progression with type 2 diabetes and elevated BMI.
Charlotte RobinsonChronic Kidney Disease | March 31, 2025
Could a combined nutritional supplementation and exercise training program improve frailty and health outcomes with CKD?
Charlotte RobinsonChronic Kidney Disease | March 25, 2025
Is metformin use ever appropriate for patients with advanced kidney disease and type 2 diabetes?
Charlotte RobinsonChronic Kidney Disease | March 31, 2025
A study compared stroke and dementia risk between race-free and previous eGFR equations.
Charlotte RobinsonChronic Kidney Disease | March 21, 2025
Researchers estimated tuberculosis incidence and described the disease among the US population with kidney failure.
Charlotte RobinsonChronic Kidney Disease | March 12, 2025
Furosemide (Furoscix) has been approved by the FDA for the treatment of edema in patients with chronic kidney disease (CKD).
Lauren Budd Levy, MS, RDN, CSRNKF Spring Clinical Meetings 2025 | March 27, 2025
Dietitian Lauren Budd Levy explains the importance of renal nutrition and related sessions at NKF SCM25.
Charlotte RobinsonChronic Kidney Disease | March 28, 2025
Canagliflozin increased total iron binding capacity and decreased ferritin in patients with type 2 diabetes and CKD.
Charlotte RobinsonChronic Kidney Disease | March 31, 2025
A study evaluated the effectiveness of spironolactone for reducing adverse cardiovascular outcomes in older adults with CKD.
Charlotte RobinsonChronic Kidney Disease | April 1, 2025
Researchers studied the efficacy of exercise in improving cognitive function in people with CKD and its potential harm.
Charlotte RobinsonChronic Kidney Disease | April 1, 2025
A study examined MPS-based gene panel testing in patients with unexplained CKD in a real-world context.
Charlotte RobinsonChronic Kidney Disease | April 1, 2025
Can lower home systolic BP targets be met in patients with CKD through antihypertensive medications and home BP monitoring?
Charlotte RobinsonChronic Kidney Disease | February 26, 2025
Research examined the role of serum phosphate in CKD-associated pruritus and the efficacy of treatment with difelikefalin.
Charlotte RobinsonChronic Kidney Disease | February 21, 2025
Novo Nordisk is suing KBP Biosciences over alleged fraudulent claims about the kidney disease drug ocedurenone.
Charlotte RobinsonAnemia and Kidney Disease | March 11, 2025
A team analyzed sotagliflozin's effects on hemoglobin in patients with stage 3-4 CKD and type 2 diabetes.
Charlotte RobinsonHyperkalemia | February 12, 2025
A study compared the risks of cardiovascular events in hospital settings among patients with CKD with and hyperkalemia.
Charlotte RobinsonChronic Kidney Disease | February 12, 2025
Eli Lilly ended a phase II trial of volenrelaxin in chronic kidney disease "due to a lack of foreseeable clinical benefit."
Victoria SochaChronic Kidney Disease | March 31, 2025
Previous studies suggest a link between CKD and sleep disorders, but the nature of the association is unclear.
Charlotte RobinsonChronic Kidney Disease | April 1, 2025
Using NURTuRE-CKD data, researchers studied kidney outcomes and heterogeneity of risk by primary renal diagnosis.
Advertisement